- KU School of Nursing ranks 22nd on U.S. News Best Colleges ranking
Sep 14, 2021 -- U.S. News and World Report in its 2022 Best Colleges list ranked the University of Kansas School of Nursing 22nd among other public colleges and universities surveyed that offer a Bachelor of Science in Nursing (BSN).
- TSCORE LIFT program to create health science learning opportunities for underserved Kansas high school students
Sep 08, 2021 -- The program connects high school teachers at Kansas City, Wichita, Topeka, Lawrence and Hays school districts with local health systems and university faculty so that they can work together to create a health science curriculum and provide work-based learning experiences to students who otherwise might not have that opportunity.
- KU Alzheimer’s Disease Research Center receives $15 million and second renewal as one of 31 nationally designated centers by the National Institute on Aging
Aug 31, 2021 -- The University of Kansas Medical Center has announced that the National Institute on Aging has renewed the University of Kansas Alzheimer’s Disease Research Center’s (KU ADRC) national designation. The accompanying five-year grant will provide more than $15 million for the KU ADRC through 2026.
- Study published in NEJM shows breakthrough drug can benefit more people with cystic fibrosis
Aug 25, 2021 -- According to a study published in the New England Journal of Medicine and co-led by Deepika Polineni, M.D., MPH, an associate professor in the Division of Pulmonary, Critical Care and Sleep Medicine at KU Medical Center, Trikafta can provide additional benefit for CF patients who have genetic mutations that made them eligible for previously approved CFTR modulators.
- International panel of experts releases first consistent guidelines for protecting bone health of childhood cancer survivors
Aug 20, 2021 -- Children and teenagers who survive cancer can have problems with their bone health later in life because cancer treatments such as radiation and chemotherapy can reduce bone mineral density (BMD).
- Early trial results indicate Yescarta CAR-T therapy improves survival for adults who relapse from large B-cell lymphoma
Aug 04, 2021 -- Yescarta is 60% more effective than the current standard of care in treating people with large B-cell lymphoma (LBCL) who did not respond well to, or relapsed after, the first line of treatment, according to early results of a global Phase 3 clinical trial.
- Dementia researchers issue urgent call for more diversity in clinical trial participation
Jul 22, 2021 -- Experts say research participation from African Americans and other groups heavily impacted by Alzheimer’s is key to finding drugs and treatments that work for everyone.
- Professor pivots from Kenya to Kansas (and back again) to serve global health needs in pandemic
Jul 08, 2021 -- KU Medical Center Professor Sarah Finocchario Kessler adapted a program she used in her HIV research in Africa to help health departments in Wyandotte and Johnson counties as they assisted those with COVID-19. Kessler then offered that same adaptation to her health care partners in Kenya.
- Study to assess post-vax COVID-19 antibodies in people with cancer
Jul 01, 2021 -- The goal of the study is to build on early knowledge of how the COVID-19 vaccine works in patients with cancer who, depending on the type of treatment they are undergoing, may have a suppressed or over-stimulated immune system.
- KU Medical Center assists community partners in launching campaign against COVID-19 in multiple languages across Kansas
Jun 22, 2021 -- The University of Kansas Medical Center and community partners across 10 Kansas counties are launching a multimedia campaign “Community Workers Beat the Virus” to encourage COVID-19 testing and vaccination among under-resourced populations. This initiative is part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) program.
- Clinical trial network aims to speed up development of effective treatments for rare type of muscular dystrophy
Jun 18, 2021 -- The multisite international Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN) is led by researchers at KU Medical Center and the University of Rochester Medical Center.
- Meet KU School of Health Professions’ new associate dean for research, Jacob Sosnoff
Jun 14, 2021 -- Jacob Sosnoff, Ph.D., takes on the role of associate dean for research at the University of Kansas School of Health Professions. His research interests are mobility issues and fall prevention.
Last modified: Jul 26, 2018